Drug repositioning meets precision in glioblastoma
Glioblastoma has a gigantic unmet medical need. Molecular knowledge has evolved substantially, including data on clonal selection with progression. Past trials for all-comers may have produced false negative results. Molecular precision at progression needs workup of new tissue, and revisiting drugs...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 2018
|
| In: |
Clinical cancer research
Year: 2018, Jahrgang: 24, Heft: 2, Pages: 256-258 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-17-2989 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1158/1078-0432.CCR-17-2989 Verlag, kostenfrei, Volltext: http://clincancerres.aacrjournals.org/content/24/2/256 
|
| Verfasserangaben: | Wolfgang Wick, Tobias Kessler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572266937 | ||
| 003 | DE-627 | ||
| 005 | 20230426124252.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180423s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1078-0432.CCR-17-2989 |2 doi | |
| 035 | |a (DE-627)1572266937 | ||
| 035 | |a (DE-576)502266937 | ||
| 035 | |a (DE-599)BSZ502266937 | ||
| 035 | |a (OCoLC)1341007379 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 245 | 1 | 0 | |a Drug repositioning meets precision in glioblastoma |c Wolfgang Wick, Tobias Kessler |
| 264 | 1 | |c January 2018 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.04.2018 | ||
| 520 | |a Glioblastoma has a gigantic unmet medical need. Molecular knowledge has evolved substantially, including data on clonal selection with progression. Past trials for all-comers may have produced false negative results. Molecular precision at progression needs workup of new tissue, and revisiting drugs with a focus on brain tumor penetration may yield surprises. Clin Cancer Res; 24(2); 256-8. ©2017 AACR. See related article by Byron et al., p. 295 | ||
| 700 | 1 | |a Keßler, Tobias |d 1987- |e VerfasserIn |0 (DE-588)1104151693 |0 (DE-627)86164591X |0 (DE-576)470840277 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cancer research |d Philadelphia, Pa. [u.a.] : AACR, 1995 |g 24(2018), 2, Seite 256-258 |h Online-Ressource |w (DE-627)325489971 |w (DE-600)2036787-9 |w (DE-576)094502234 |x 1557-3265 |7 nnas |a Drug repositioning meets precision in glioblastoma |
| 773 | 1 | 8 | |g volume:24 |g year:2018 |g number:2 |g pages:256-258 |g extent:3 |a Drug repositioning meets precision in glioblastoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1158/1078-0432.CCR-17-2989 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://clincancerres.aacrjournals.org/content/24/2/256 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180423 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1104151693 |a Keßler, Tobias |m 1104151693:Keßler, Tobias |d 910000 |d 911100 |e 910000PK1104151693 |e 911100PK1104151693 |k 0/910000/ |k 1/910000/911100/ |p 2 |y j | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1572266937 |e 3006907450 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1572266937"],"doi":["10.1158/1078-0432.CCR-17-2989"]},"origin":[{"dateIssuedDisp":"January 2018","dateIssuedKey":"2018"}],"relHost":[{"pubHistory":["1.1995 -"],"title":[{"title_sort":"Clinical cancer research","title":"Clinical cancer research"}],"name":{"displayForm":["American Association for Cancer Research"]},"origin":[{"dateIssuedKey":"1995","publisherPlace":"Philadelphia, Pa. [u.a.]","publisher":"AACR","dateIssuedDisp":"1995-"}],"part":{"year":"2018","extent":"3","volume":"24","pages":"256-258","text":"24(2018), 2, Seite 256-258","issue":"2"},"id":{"zdb":["2036787-9"],"eki":["325489971"],"issn":["1557-3265"]},"disp":"Drug repositioning meets precision in glioblastomaClinical cancer research","type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Association for Cancer Research"}],"language":["eng"],"recId":"325489971","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"]}],"physDesc":[{"extent":"3 S."}],"recId":"1572266937","language":["eng"],"note":["Gesehen am 23.04.2018"],"person":[{"display":"Wick, Wolfgang","roleDisplay":"VerfasserIn","role":"aut","family":"Wick","given":"Wolfgang"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Keßler, Tobias","given":"Tobias","family":"Keßler"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Drug repositioning meets precision in glioblastoma","title":"Drug repositioning meets precision in glioblastoma"}],"name":{"displayForm":["Wolfgang Wick, Tobias Kessler"]}} | ||
| SRT | |a WICKWOLFGADRUGREPOSI2018 | ||